DPP4 and Hypoglycemia: Moreover, DPP‐4 inhibitors were shown to associate with a lower incidence of hypoglycemia and gastrointestinal side effects [26], rendering them an important alternative in cases of metformin intolerance or hypoglycemia concerns.